Ipsen: AZZALURE(R) Approved In Spain For Aesthetic Use In The Treatment Of Glabellar Lines
Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has